Fish Oil Supplements May Speed Cognitive Decline

Causing faster cognitive decline in older adults.

Fish, fish oil pills, pitcher of o
Adobe Stock

Many of us get told to take omega 3 fish oil supplements for our overall health and specifically to take care of our brain. However, new research suggests that fish oil supplements could accelerate cognitive decline. 

Faster Cognitive Decline In Older Adults 

Recently, researchers found that older adults who took omega-3 supplements experienced significantly faster cognitive decline than those who did not.

This Chinese study released in June 2026 analyzed data from 819 participants in the Alzheimer's Disease Neuroimaging Initiative, a large, on-going North American study on dementia. Cognitively healthy older adults, people with mild cognitive impairment, and individuals with Alzheimer's disease were followed for an about five years.

After accounting for factors such as age, sex, APOE  genetic status (having known Alzheimer's genes), and diagnosis, omega-3 users showed a steeper decline on several widely used measures of cognition. Their cognition was charted on the Mini-Mental State Examination (MMSE), the Alzheimer's Disease Assessment Scale-Cognitive Subscale, (ADAS-Cog13) and the Clinical Dementia Rating Scale

The findings challenge a common assumption that omega-3 supplements are broadly beneficial for cognitive health.

Looking Beyond Alzheimer's Pathology

Surprisingly, omega-3 supplementation was not associated with greater amyloid buildup, increased tau pathology, or accelerated loss of gray matter volume, the hallmarks of Alzheimer's disease.

Alternatively, fish oil supplements might be involved brain metabolism.

Participants who used omega-3 supplements showed a greater decline in glucose metabolism in brain regions known to be vulnerable to Alzheimer's disease. Brain cells rely heavily on glucose for energy. Reduced glucose metabolism is considered a sign of impaired neuronal and synaptic function.

The researchers found that reduced glucose metabolism accounted for nearly 31% of the effect on MMSE decline, 41% of the effect on worsening ADAS-Cog13 scores, and 19% of the effect on worsening Clinical Dementia Rating scores. 

This suggest that the fish oil supplements are interfering with synaptic function rather than traditional Alzheimer's pathology as a potential mechanism. Synapses are what allow for communication within the brain. Even small disturbances in synapses can be significant. 

Study Limitations

The authors emphasize that the study does not prove omega-3 supplements cause cognitive decline. The research was observational, so unmeasured factors could have influenced the results. Although the researchers matched participants on several important characteristics and found no evidence that future supplement users were already declining more rapidly before they started taking omega-3 products, other differences between the groups may still exist.

The study also could not determine the exact dosage participants took or how consistently they used the supplements over time. Most participants who reported omega-3 use were taking fish oil, so the findings may not apply equally to all omega-3 formulations.

Omega-3 molecules are highly susceptible to oxidation. Under some circumstances, oxidation products may damage mitochondria, interfere with energy production, and increase oxidative stress within brain cells. This could help explain why some clinical trials have failed to find cognitive benefits from omega-3 supplementation despite promising results from animal studies and observational research.